© 2022 MJH Life Sciences and Cancer Network. All rights reserved.
June 15, 2017
In this interview we discuss the role of checkpoint inhibitors in advanced lung cancer and treatment strategies when patients progress.
In a Significant Percentage of Patients, Neoadjuvant Therapy Yields Equivalent Survival, With Better Quality of Life and Lower Costs
Cytoreductive Surgery Is the Best Way to Affect Survival Outcomes